Filing Details
- Accession Number:
- 0001136261-20-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-14 16:36:58
- Reporting Period:
- 2020-02-13
- Accepted Time:
- 2020-02-14 16:36:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1017491 | Seelos Therapeutics Inc. | SEEL | Pharmaceutical Preparations (2834) | 870449967 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1757892 | Raj Mehra | C/O Seelos Therapeutics, Inc. 300 Park Avenue, 12Th Floor New York NY 10022 | See Remarks | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-02-13 | 133,333 | $0.75 | 3,214,879 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
